Manci Li

Dr. Manci Li

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
GRGage Rowden
Gage Rowden
Catalina Picasso RissoCatalina Picasso Risso
Catalina Picasso Risso
MLManci Li
Manci Li
MSMarc Schwabenlander
Marc Schwabenlander
TWTiffany Marie Wolf
Tiffany Marie Wolf
PLPeter Larsen
Peter Larsen
Chronic wasting disease (CWD) is a disease affecting cervids and is caused by prions accumulating as pathogenic fibrils in lymphoid tissue and the central nervous system. Approaches for detecting CWD prions historically relied on antibody-based assays. However, recent advancements in protein amplification technology provided the foundation for a new class of CWD diagnostic tools. In particular, real-time quaking-induced conversion (RT-QuIC) has rapidly become a feasible option for CWD diagnosis. Despite its increased usage for CWD-focused research, there lacks a consensus regarding the interpretation of RT-QuIC data for diagnostic purposes. It is imperative then to identify a standardized and replicable method for determining CWD status from RT-QuIC data. Here, we assessed variables that could impact RT-QuIC results and explored the use of maxpoint ratios (maximumRFU/backgroundRFU) to improve the consistency of RT-QuIC analysis. We examined a variety of statistical analyses to retrospectively analyze CWD status based on RT-QuIC and ELISA results from 668 white-tailed deer lymph nodes. Our results revealed an MPR threshold of 2.0 for determining the rate of amyloid formation, and MPR analysis showed excellent agreement with independent ELISA results. These findings suggest that the use of MPR is a statistically viable option for normalizing between RT-QuIC experiments and defining CWD status.

24 December 2024 in Bioinformatics
Verified
Journal Article
Open access
MLManci Li
Manci Li
DBDamani Bryant
Damani Bryant
SGSarah Gresch
Sarah Gresch
MMMarissa S Milstein
Marissa S Milstein
PCPeter R Christenson
Peter R Christenson
SOSang-Hyun Oh
Sang-Hyun Oh
Motivation: Fluorophore-assisted seed amplification assays (F-SAAs), such as real-time quaking-induced conversion (RT-QuIC) and fluorophore-assisted protein misfolding cyclic amplification (F-PMCA), have become indispensable tools for studying protein misfolding in neurodegenerative diseases. However, analyzing data generated by these techniques often requires complex and time-consuming manual processes. In addition, the lack of standardization in F-SAA data analysis presents a significant challenge to the interpretation and reproducibility of F-SAA results across different laboratories and studies. There is a need for automated, standardized analysis tools that can efficiently process F-SAA data while ensuring consistency and reliability across different research settings. Results: Here, we present QuICSeedR (pronounced as “quick seeder”), an R package that addresses these challenges by providing a comprehensive toolkit for the automated processing, analysis, and visualization of F-SAA data. Importantly, QuICSeedR also establishes the foundation for building an F-SAA data management and analysis framework, enabling more consistent and comparable results across different research groups. Availability and implementation: QuICSeedR is freely available at: https://CRAN.R-project.org/package=QuICSeedR. Data and code used in this manuscript are provided in Supplementary Materials.

27 November 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
MLManci Li
Manci Li
NFNicole Flack
Nicole Flack
PLPeter Larsen
Peter Larsen
Regarding Alzheimer’s disease (AD), specific neuronal populations and brain regions exhibit selective vulnerability. Understanding the basis of this selective neuronal and regional vulnerability is essential to elucidate the molecular mechanisms underlying AD pathology. However, progress in this area is currently hindered by the incomplete understanding of the intricate functional and spatial diversity of neuronal subtypes in the human brain. Previous studies have demonstrated that neuronal subpopulations with high neuropeptide (NP) co-expression are disproportionately absent in the entorhinal cortex of AD brains at the single-cell level, and there is a significant decline in hippocampal NP expression in naturally aging human brains. Given the role of NPs in neuroprotection and the maintenance of microenvironments, we hypothesize that neurons expressing higher levels of NPs (HNP neurons) possess unique functional characteristics that predispose them to cellular abnormalities, which can manifest as degeneration in AD with aging. To test this hypothesis, multiscale and spatiotemporal transcriptome data from ~1900 human brain samples were analyzed using publicly available datasets. The results indicate that HNP neurons experienced greater metabolic burden and were more prone to protein misfolding. The observed decrease in neuronal abundance during stages associated with a higher risk of AD, coupled with the age-related decline in the expression of AD-associated neuropeptides (ADNPs), provides temporal evidence supporting the role of NPs in the progression of AD. Additionally, the localization of ADNP-producing HNP neurons in AD-associated brain regions provides neuroanatomical support for the concept that cellular/neuronal composition is a key factor in regional AD vulnerability. This study offers novel insights into the molecular and cellular basis of selective neuronal and regional vulnerability to AD in human brains.

19 June 2025 in Stem Cells
Verified
Journal Article
Closed access
HHHuzefa I Husain
Huzefa I Husain
MLManci Li
Manci Li
JAJuan Abrahante
Juan Abrahante
NMNatalia Calixto Mancipe
Natalia Calixto Mancipe
AVAmanda Vegoe
Amanda Vegoe
FTFerenc Tóth
Ferenc Tóth
Existing protocols for in vitro hyaline cartilage production utilizing human induced pluripotent stem cells (hiPSCs) have several challenges including a complex culturing process that uses undefined culture media, phenotypic instability, and batch-to-batch variability of the cell product. Here, our primary objective is to describe a simple, xeno- and feeder-free protocol for the generation of hyaline cartilage utilizing multi-tissue organoids (MTOs). We investigated gene regulatory networks during hiPSC-MTO differentiation using RNA sequencing and bioinformatics analyses, as well as histological and immunohistochemical methods. Interplays between bone morphogenetic protein (BMP) and neural fibroblast growth factor (FGF) pathways associated with the phenotypic transition of MTOs are described. Comparisons across transcriptomes revealed that the expression of chondrocyte-specific genes in MTOs correlates strongly with fetal lower limb chondrocytes. Single-cell RNA sequencing findings confirmed that the majority of cells belonged to the chondrogenic lineage and that they were similar across MTO batches, suggesting uniformity of the culture process. Collectively, these findings demonstrate the consistent emergence of hyaline cartilage in MTOs and the molecular pathways that govern this process, thereby establishing an accessible source of functional chondrocytes for future therapeutic evaluations.

14 November 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
MLManci Li
Manci Li
PLPeter A. Larsen
Peter A. Larsen
Alzheimer’s disease (AD) is a fatal neurodegenerative disease that involves early and significant neuropathological changes within the entorhinal cortex (EC). Many have reported on neuronal loss and synaptic dysfunction in the brains of AD patients and AD models. In parallel, abnormalities of neuropeptides (NPs) that play important roles in modulating neuronal activities are commonly observed in AD and other neurodegenerative diseases. However, the involvement of NPs has mostly been studied in the context of neurons; a cell type-specific examination of NP expression in AD brains is needed. Here, we aim to examine the NP networks in the EC of AD brains using single-nuclei and bulk transcriptomic data from other regions in the temporal cortex, focusing on the gene expression of NP and their cognate G-protein coupled receptors. We find that NP genes were expressed by all major cell types in the brain and there was a significant decrease in the quantity and the proportion of cells that express NPs in AD EC cells. On the contrary, the overall expression of GPCR genes showed an increase in AD cells, likely reflecting ongoing compensatory mechanisms in AD brains. In addition, we report that there was a disproportionate absence of cells expressing higher levels and greater diversity of NPs in AD brains. Finally, we established a negative correlation between age and the abundance of AD-associated NPs in the hippocampus, supporting that the disruption of the NP signaling network in the EC may contribute to the early pathogenesis of AD. In short, we report widespread disruption of the NP networks in AD brains at the single-cell level. In light of our results, we hypothesize that brain cells, especially neurons, that express high levels of NPs may exhibit selective vulnerability to AD. Moreover, it is likely AD brains undergo specific adaptive changes to fluctuating NP signaling, a process that can likely be targeted with therapeutic approaches aimed at stabilizing NP expression landscapes. Given that GPCRs are one of the most druggable targets for neurological diseases and disorders, we believe NP signaling pathways can be harnessed for future biomarkers and treatment strategies for AD.

18 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
KHKyle D. Howey
Kyle D. Howey
MLManci Li
Manci Li
PCPeter R. Christenson
Peter R. Christenson
PLPeter A. Larsen
Peter A. Larsen
SOSang-Hyun Oh
Sang-Hyun Oh
Advancements in AI, particularly deep learning, have revolutionized protein folding modeling, offering insights into biological processes and accelerating drug discovery for protein misfolding diseases. However, detecting misfolded proteins associated with neurodegenerative disorders, such as Alzheimer’s, Parkinson’s, ALS, and prion diseases, relies on Seed Amplification Assays (SAAs) analyzed through manual, time-consuming, and potentially inconsistent methods. We introduce AI-QuIC, an AI-driven platform that automates the analysis of Real-Time Quaking- Induced Conversion (RT-QuIC) assay data, a type of SAA crucial for detecting misfolded proteins. Utilizing a well-labeled RT-QuIC dataset of over 8,000 wells—the largest curated dataset for chronic wasting disease prion detection—we applied various AI models to classify true positive, false positive, and negative reactions. Notably, our deep-learning-based model achieved over 98% sensitivity and 97% specificity. By learning directly from raw fluorescence data, deep learning simplifies the SAA-analysis workflow. Automating and standardizing SAA data interpretation with AI-QuIC provides robust, scalable, and consistent diagnostic solutions.